|
embryopathie door isotretinoïne (aandoening)
embryopathie door isotretinoïne
embryopathie door 13-cis-retinoïnezuur
Isotretinoin syndrome
Embryopathy caused by isotretinoin
A rare teratogenic embryofetopathy due to exposure to isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardiovascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia.
Id1237226008
StatusDefined
Associated morphologymorfologische afwijking
Causative agentisotretinoïne
Occurrencefoetale periode
Pathological processproces van pathologische ontwikkeling
SNOMED CT to Orphanet simple map2305
SNOMED CT to ICD-10 extended map
TargetQ86.8
RuleTRUE
AdviceALWAYS Q86.8 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified
TargetP04.1
RuleTRUE
AdviceALWAYS P04.1
CorrelationSNOMED CT source code to target map code correlation not specified